This company seems to have been delisted
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Athersys
ATHX
$0.01926
Share price
-33.50%
Change (1 day)
-98.85%
Change (1 year)
Categories
Athersys (ATHX) - P/B ratio
P/B ratio as of March 2025 : -0.0229
According to Athersys's latest financial reports the company has a price-to-book ratio of 10.415.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Athersys - P/B ratio (from 2007 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -0.0339 | -94.4% |
| 2022-12-31 | -0.6061 | -104.67% |
| 2021-12-31 | 13.0 | 15.09% |
| 2020-12-31 | 11.3 | 33.44% |
| 2019-12-31 | 8.45 | 75.26% |
| 2018-12-31 | 4.82 | -47.49% |
| 2017-12-31 | 9.18 | -21.83% |
| 2016-12-31 | 11.7 | 168.55% |
| 2015-12-31 | 4.37 | -25.6% |
| 2014-12-31 | 5.88 | -34.09% |
| 2013-12-31 | 8.92 | 220.95% |
| 2012-12-31 | 2.78 | -50.14% |
| 2011-12-31 | 5.57 | 7.3% |
| 2010-12-31 | 5.19 | 25.91% |
| 2009-12-31 | 4.12 | 1427.85% |
| 2008-12-31 | 0.2699 | -86.17% |
| 2007-12-31 | 1.95 | |
| 2006-12-31 | N/A | |
| 2005-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 | 28.0 | -122,622.75% | 🇺🇸 USA |
 | 1.64 | -7,252.35% | 🇺🇸 USA |
 | 7.33 | -32,126.49% | 🇺🇸 USA |
 | 1.20 | -5,344.11% | 🇺🇸 USA |
 | 5.45 | -23,912.25% | 🇺🇸 USA |
 | 5.34 | -23,428.79% | 🇺🇸 USA |
 | 4.80 | -21,065.30% | 🇺🇸 USA |
 | 1.70 | -7,527.54% | 🇫🇷 France |